peoplePerson
Priyanka Sharma
Priyanka Sharma is a TNBC trialist testing whether anthracyclines can be dropped from pre-surgery treatment.
Breast medical oncologist who led NeoSTOP and the SWOG S2212 SCARLET trial comparing anthracycline-free carboplatin-docetaxel plus pembrolizumab with the KEYNOTE-522 regimen.
Role
Professor of Medicine, University of Kansas Cancer Center; Study Chair, SWOG S2212 (SCARLET)
Institution
Specialisms
Triple-negative breast cancerPlatinum chemotherapyDe-escalation trials
Pages like this
not linked directly; found by shared links- IdeaNeoadjuvant ADC + IO replacing anthracycline chemotherapy in TNBC
Shares SCARLET (SWOG S2212), Pembrolizumab, Triple-negative breast cancer (TNBC).
- PersonMariana Chavez-MacGregor
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- PersonDawn L. Hershman
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- TrialSWOG S1801
- PairingPlatinum chemotherapy in HRD tumours
- TrialKEYNOTE-355
- TrialOptimICE-pCR (A012103)
- TrialTROPION-Breast05